A Gene Panel Associated With Abemaciclib Utility in <i>ESR1</i>-Mutated Breast Cancer After Prior Cyclin-Dependent Kinase 4/6-Inhibitor ProgressionJamie O. Brett, Seth A. Wander, Taronish D. Dubash et al.|JCO Precision Oncology|2023Cited by 16
Abstract PR08: Intratumoral heterogeneity drives resistance to Antibody Drug Conjugate therapy: Analysis of the NeoSTAR trial of neoadjuvant Sacituzumab govitecan for localized TNBCLaura M. Spring, Leif W. Ellisen, Simona Cristea et al.|Cancer Research|2024Cited by 2